Building better monoclonal antibody-based therapeutics
GJ Weiner - Nature Reviews Cancer, 2015 - nature.com
For 20 years, monoclonal antibodies (mAbs) have been a standard component of cancer
therapy, but there is still much room for improvement. Efforts continue to build better cancer …
therapy, but there is still much room for improvement. Efforts continue to build better cancer …
[PDF][PDF] Building better monoclonal antibody-based therapeutics
GJ Weiner - Nat Rev Cancer, 2015 - roswellpark.org
For 20 years, monoclonal antibodies (mAbs) have been a standard component of cancer
therapy, yet there is still much room for improvement. Efforts continue to build better cancer …
therapy, yet there is still much room for improvement. Efforts continue to build better cancer …
[引用][C] Building better monoclonal antibody-based therapeutics
GJ Weiner - Nature Reviews Cancer, 2015 - cir.nii.ac.jp
Building better monoclonal antibody-based therapeutics.
GJ Weiner - Nature reviews. Cancer, 2015 - europepmc.org
For 20 years, monoclonal antibodies (mAbs) have been a standard component of cancer
therapy, yet there is still much room for improvement. Efforts continue to build better cancer …
therapy, yet there is still much room for improvement. Efforts continue to build better cancer …
Building better monoclonal antibody-based therapeutics
GJ Weiner - Nature Reviews Cancer, 2015 - go.gale.com
For 20 years, monoclonal antibodies (mAbs) have been a standard component of cancer
therapy, but there is still much room for improvement. Efforts continue to build better cancer …
therapy, but there is still much room for improvement. Efforts continue to build better cancer …
Building better monoclonal antibody-based therapeutics.
GJ Weiner - Nature Reviews Cancer, 2015 - search.ebscohost.com
For 20 years, monoclonal antibodies (mAbs) have been a standard component of cancer
therapy, but there is still much room for improvement. Efforts continue to build better cancer …
therapy, but there is still much room for improvement. Efforts continue to build better cancer …
Building better monoclonal antibody-based therapeutics
GJ Weiner - Nature reviews. Cancer, 2015 - iro.uiowa.edu
For 20 years, monoclonal antibodies (mAbs) have been a standard component of cancer
therapy, but there is still much room for improvement. Efforts continue to build better cancer …
therapy, but there is still much room for improvement. Efforts continue to build better cancer …
[HTML][HTML] Building better monoclonal antibody-based therapeutics
GJ Weiner - Nature reviews. Cancer, 2015 - ncbi.nlm.nih.gov
For 20 years, monoclonal antibodies (mAbs) have been a standard component of cancer
therapy, yet there is still much room for improvement. Efforts continue to build better cancer …
therapy, yet there is still much room for improvement. Efforts continue to build better cancer …
Building better monoclonal antibody-based therapeutics
GJ Weiner - Nature reviews. Cancer, 2015 - pubmed.ncbi.nlm.nih.gov
For 20 years, monoclonal antibodies (mAbs) have been a standard component of cancer
therapy, but there is still much room for improvement. Efforts continue to build better cancer …
therapy, but there is still much room for improvement. Efforts continue to build better cancer …